alpha pharma retatrutide — ZO Peptides Retatrutide | Triple Agonist Research
Description
Our experienced team is here to support you every step of the way, including helping you manage any side effects you may experience during your first week on the medication
GLP-1: Slows digestion Lowers appetite Helps the body release insulin only when blood sugar is high GLP-1 medications mimic these effects
National Institute of Diabetes and Digestive and Kidney Diseases
What can I expect during my New Patient Consultation and Intake process
Retatrutide is the first of these triple-agonists to reach trials, and early results suggest it could result in up to 30% body weight loss in around 68 weeks
